Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.36ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.36ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-4212.07Germany
BA.2.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.36EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
BA.2.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BE.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LS.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LS.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LS.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LS.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LS.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1 (Omicron)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1 (Omicron)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1 (Omicron)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1 (Omicron)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1 (Omicron)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1 (Omicron)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1 (Omicron)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used